Alpha Teknova, Inc.
TKNONext catalyst
No upcoming catalyst in our data
No upcoming FDA decision, filing or trial readout is on file for TKNO. That does not mean none is planned.
Get an email about TKNO's next catalysts
Track Alpha Teknova (TKNO) and we email you when an FDA date moves, 7 days and 1 day before the decision when the exact day is known, and when it is announced. Free account, no card.
0 upcoming, 3 past
No catalysts found.
Market Overview
Stock performance and key metrics
| Drug Name | Phase | Indication | Designations | Patent |
|---|---|---|---|---|
AZD3759 | Phase 2 | Non Small Cell Lung Cancer | - | - |
Frequently asked questions
What is in Alpha Teknova, Inc.'s drug pipeline?→
CatalystAlert tracks 1 drug candidate in Alpha Teknova, Inc.'s (TKNO) pipeline across Phase 2. Its lead program is AZD3759 (Phase 2). Each drug's phase, indication and upcoming catalysts are listed on this page.
When is Alpha Teknova, Inc.'s next FDA catalyst?→
CatalystAlert tracks every upcoming catalyst for Alpha Teknova, Inc. (TKNO) — PDUFA decision dates, Phase 1/2/3 trial readouts, FDA advisory committee meetings and NDA/BLA filings — each confidence-rated as confirmed, estimated or AI-detected.
How do I track TKNO biotech catalysts?→
Add TKNO to your CatalystAlert watchlist for alerts ahead of each catalyst, and follow Alpha Teknova, Inc.'s live catalyst calendar, drug pipeline and clinical-trial timeline on this page — sourced from ClinicalTrials.gov, FDA and SEC filings.